Controlled release and antibacterial activity chlorhexidine acetate (CA) intercalated in montmorillonite

International Journal of Pharmaceutics

Volumn 382, Issue 1-2, 2009, Pages 45-49

  Meng, Na ^a   Zhou, Ning Lin ^a,b   Zhang, Shuang Quan ^a   Shen, Jian ^a,b  

^a NANJING NORMAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Antibacterial activity; Chlorhexidine acetate; Continuously release; Montmorillonite

Indexed keywords

CHLORHEXIDINE ACETATE; MONTMORILLONITE; PHOSPHATE BUFFERED SALINE;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; INFRARED SPECTROSCOPY; INTERCALATION COMPLEX; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; THERMOGRAVIMETRY; X RAY DIFFRACTION;

ANTI-BACTERIAL AGENTS; BENTONITE; CHEMISTRY, PHARMACEUTICAL; CHLORHEXIDINE; CRYSTALLOGRAPHY, X-RAY; DELAYED-ACTION PREPARATIONS; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG CARRIERS; DRUG COMPOUNDING; KINETICS; PSEUDOMONAS AERUGINOSA; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STAPHYLOCOCCUS AUREUS; TECHNOLOGY, PHARMACEUTICAL; THERMOGRAVIMETRY;

EID: 70350194760     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.08.004     Document Type: Article

References (28)

1. Akelah A. Polymer-clay nanocomposites: free-radical grafting of polystyrene on to organophilic montmorillonite interlayers. J. Mater. Sci. 31 (1996) 3589-3596
2. Alther, G., 2000. Bactericidal organoclay for water disinfection containing quaternary amine and iodine. US Patent 6,165,485.
3. Aly R., and Maibach H.I. Comparative study on the antimicrobial effect of 0.5% chlorhexidine gluconate and 70% isopropyl alcohol on the normal flora of hands. Appl. Environ. Microb. 37 (1979) 610-613
4. Dizman B., Badger J.C., Elasri M.O., and Mathias E.L. Antibacterial fluoromicas: a novel delivery medium. Appl. Clay Sci. 38 (2007) 57-63
5. Dong Y., and Feng S.S. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Biomaterials 26 (2005) 6068
6. Frantz S.W., Haines K.A., Azar C.G., Ward J.I., Homan S.M., and Roberts R.B. Chlorhexidine gluconate (CHG) activity against clinical isolates of vancomycin-resistant Enterococcus faecium (VREF) and the effects of moisturizing agents on CHG residue accumulation on the skin. J. Hosp. Infect. 37 (1997) 157-164
7. Fejer I., Kata M., Eros I., Berkesi O., and Dekani I. Release of cationic drugs from loaded clay minerals. Colloid Polym. Sci. 279 (2001) 1177
8. Gao J.M., Gu Z., Song G.J., Li P.Y., and Liu W.D. Preparation and properties of organo-montmorillonite/fluoroelastomer nanocomposites. Appl. Clay Sci. 42 (2008) 272-275
9. Guilbeaux R. Biocidal clay thickening additive for an organic composition, specifically a cosmetic preparation. Eur. Pat. Appl. 265 (1988) 101
10. Herrera P., Burghardt R.C., and Phillips T.D. Adsorption of Salmonella enteritidis by cetylpyridinium-exchanged montmorillonite clays. Vet. Microbiol. 74 (2000) 259-272
11. Herrera P., Burghardt R., Huebner H.J., and Phillips T.D. The efficacy of sand-immobilized organoclays as filtration bed materials for bacteria. Food Microbiol. 21 (2004) 1-10
12. Hu C.H., and Xia M.S. Adsorption and antibacterial effect of copper-exchanged montmorillonite on Escherichia coli K88. Appl. Clay Sci. 31 (2006) 180-184
13. Jantova S., Labuda J., Vollek V., and Zastkova M. Antimicrobial effects of the macrocyclic Cu (II)-tetraanhydroaninobenzaldehyde complex. Folia Microbiol. Prague 42 (1997) 324-326
14. Joshi G.V., Kevadiya B.D., Patel H.A., Bajaj H.C., and Jasra R.V. Montmorillonite as a drug delivery system: Intercalation and in vitro release of timolol maleate. Int. J. Pharm. 374 (2009) 53-57
15. Jung H., Kim H.M., Choy Y.B., Hwang S.J., and Choy J.H. Laponite-based nanohybrid for enhanced solubility and controlled release of itraconazole. Int. J. Pharm. 349 (2008) 283-290
16. Khalil H., Mahajan D., and Rafailovich M. Polymer-montmorillonite clay nanocomposites. Part 1. Complexation of montmorillonite clay with a vinyl monomer. Polym. Int. 54 (2005) 423-427
17. Labadie J.C., Kampf G., Lejeune B., Exner M., Cottron O., Girard R., Orlick M., Goetz M.L., Darbord J.-C., Kramer, et al. Recommendations for surgical hand disinfection-requirements, implementation and need for research. A proposal by representatives of the SFHH, DGHM and DGKH for a European discussion. J. Hosp. Infect. 51 (2002) 312-315
18. Lboutounne H., Faivre V., Falson F., and Pirot F. Characterization of transport of chlorhexidine-loaded nanocapsules through hairless and wistar rat skin. Skin Pharmacol. 17 (2004) 176-182
19. Lin F.H., Lee Y.H., Jian C.H., Wong J.M., Shieh M.J., and Wang C.Y. A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier. Biomaterials 23 (2002) 1981
20. Mohanambe L., and Vasudevan S. Anionic clays containing anti-inflammatory drug molecules: comparison of molecular dynamics simulation and measurements. J. Phys. Chem. B 109 (2005) 15651-15658
21. Patel H.A., Somani R.S., Bajaj H.C., and Jasra R.V. Preparation and characterization of phosphonium montmorillonite with enhanced thermal stability. Appl. Clay Sci. 35 (2007) 194
22. Pavia D.L., Lampman G.M., and Kriz G.S. Introduction to Spectroscopy (1996), Harcourt Brace College
23. Park J.K., Choy Y.B., Oh J.M., Kim J.Y., Hwang S.J., and Choy J.H. Int. J. Pharm. 359 (2008) 198-204
24. Singh S., Wegmann J., Albert K., and Muller K. Variable temperature FT-IR studies of n-alkyl modified silica gels. J. Phys. Chem. B 106 (2002) 878-888
25. Wang X., Du1 Y., and Luo J. Biopolymer/montmorillonite nanocomposite: preparation, drug-controlled release property and cytotoxicity. Nanotechnology 19 (2008) 065707
26. Wang J., Li J.X., Ren L., Zhao A.S., Li P., Leng Y.X., Sun H., and Huang N. Antibacterial activity of silver surface modified polyethylene terephthalate by filtered cathodic vacuum arc method. Surf. Coat. Technol. 201 (2007) 6893-6896
27. Zheng J.P., Luan L., Wang H.Y., Xi L.F., and Yao K.D. Study on ibuprofen/montmorillonite intercalation composites as drug release system. Appl. Clay Sci. 36 (2007) 297
28. 2+-montmorillonite. Appl. Clay Sci. 27 (2004) 215-218